BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30040228)

  • 1. Engineering Point Mutant and Epitope-Tagged Alleles in Mice Using Cas9 RNA-Guided Nuclease.
    Gertsenstein M; Nutter LMJ
    Curr Protoc Mouse Biol; 2018 Mar; 8(1):28-53. PubMed ID: 30040228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
    Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
    Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease.
    Qin W; Dion SL; Kutny PM; Zhang Y; Cheng AW; Jillette NL; Malhotra A; Geurts AM; Chen YG; Wang H
    Genetics; 2015 Jun; 200(2):423-30. PubMed ID: 25819794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
    Chen S; Lee B; Lee AY; Modzelewski AJ; He L
    J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Editing in Mouse Zygotes Using the CRISPR/Cas9 System.
    Wefers B; Wurst W; Kühn R
    Methods Mol Biol; 2023; 2631():207-230. PubMed ID: 36995669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroporation of Cas9 protein/sgRNA into early pronuclear zygotes generates non-mosaic mutants in the mouse.
    Hashimoto M; Yamashita Y; Takemoto T
    Dev Biol; 2016 Oct; 418(1):1-9. PubMed ID: 27474397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene editing in mouse zygotes using the CRISPR/Cas9 system.
    Wefers B; Bashir S; Rossius J; Wurst W; Kühn R
    Methods; 2017 May; 121-122():55-67. PubMed ID: 28263886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of knockout mouse lines with Cas9.
    Gertsenstein M; Nutter LMJ
    Methods; 2021 Jul; 191():32-43. PubMed ID: 33524495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor.
    Kim YS; Kim GR; Park M; Yang SC; Park SH; Won JE; Lee JH; Shin HE; Song H; Kim HR
    Tissue Eng Regen Med; 2020 Feb; 17(1):45-53. PubMed ID: 32002841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroporation of mice zygotes with dual guide RNA/Cas9 complexes for simple and efficient cloning-free genome editing.
    Teixeira M; Py BF; Bosc C; Laubreton D; Moutin MJ; Marvel J; Flamant F; Markossian S
    Sci Rep; 2018 Jan; 8(1):474. PubMed ID: 29323173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome Editing in Mice Using CRISPR/Cas9 Technology.
    Hall B; Cho A; Limaye A; Cho K; Khillan J; Kulkarni AB
    Curr Protoc Cell Biol; 2018 Dec; 81(1):e57. PubMed ID: 30178917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of PDX-1 mutant porcine blastocysts by introducing CRISPR/Cas9-system into porcine zygotes via electroporation.
    Tanihara F; Hirata M; Nguyen NT; Le QA; Hirano T; Takemoto T; Nakai M; Fuchimoto DI; Otoi T
    Anim Sci J; 2019 Jan; 90(1):55-61. PubMed ID: 30368976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimized electroporation approach for efficient CRISPR/Cas9 genome editing in murine zygotes.
    Tröder SE; Ebert LK; Butt L; Assenmacher S; Schermer B; Zevnik B
    PLoS One; 2018; 13(5):e0196891. PubMed ID: 29723268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Generation of Conditional Alleles Using CRISPR/Cas9 in Mouse Zygotes.
    Pritchard CEJ; Kroese LJ; Huijbers IJ
    Methods Mol Biol; 2017; 1642():21-35. PubMed ID: 28815491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of CRISPR-Cas9 into Mouse Zygotes by Electroporation.
    Qin W; Wang H
    Methods Mol Biol; 2019; 1874():179-190. PubMed ID: 30353514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the production of knock-in alleles by CRISPR/Cas9 microinjection into the mouse zygote.
    Raveux A; Vandormael-Pournin S; Cohen-Tannoudji M
    Sci Rep; 2017 Feb; 7():42661. PubMed ID: 28209967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Transgenic Mice Using CRISPR /Cas9 Technology.
    El Marjou F; Jouhanneau C; Krndija D
    Methods Mol Biol; 2021; 2214():125-141. PubMed ID: 32944907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing in Mice.
    Hansen LA; Füchtbauer EM
    Methods Mol Biol; 2019; 1961():249-254. PubMed ID: 30912050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysing the outcome of CRISPR-aided genome editing in embryos: Screening, genotyping and quality control.
    Mianné J; Codner GF; Caulder A; Fell R; Hutchison M; King R; Stewart ME; Wells S; Teboul L
    Methods; 2017 May; 121-122():68-76. PubMed ID: 28363792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.